Tender Details

Country: USA
Summary: Nida Avant-Garde Program For Hiv And Substance Use Disorder Research (Dp1 Clinical Trial Optional)
UST Ref No: 110536441
Deadline: 15 Aug 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: PAR-25-261
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
The Nida Avant-Garde Award Program For Hiv/Aids Research Supports Individual Scientists Of Exceptional Creativity Who Propose High-Impact Research That Will Open New Areas Of Hiv/Aids Research Relevant To Drug Abuse And/Or Lead To New Avenues For Prevention And Treatment Of Hiv/Aids Among Drug Abusers. The Term Avant-Garde Is Used To Describe Highly Innovative Approaches That Have The Potential To Be Transformative. The Proposed Research Should Reflect Approaches And Ideas That Are Substantially Different From Those Already Being Pursued By The Investigator Or Others And Should Support The Nih Hiv/Aids Research Priorities Https://Grants.Nih.Gov/Grants/Guide/Notice-Files/Not-Od-20-018.Html. The Nida Avant-Garde Award Supports Innovative, Basic Research That May Lead To Improved Preventive Interventions Or Therapies; Creative, New Strategies To Prevent Disease Transmission; Novel Approaches To Improve Disease Outcomes; And Creative Approaches To Eradicating Hiv Or Improving The Lives Of Those Living With Hiv.
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Nida Avant-Garde Program For Hiv And Substance Use Disorder Research (Dp1 Clinical Trial Optional) - USA Tender

The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Nida Avant-Garde Program For Hiv And Substance Use Disorder Research (Dp1 Clinical Trial Optional). This tender is published on USARFP under UST Ref No: 110536441 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-15.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.